000 | 01955 a2200493 4500 | ||
---|---|---|---|
005 | 20250515070713.0 | ||
264 | 0 | _c20070710 | |
008 | 200707s 0 0 eng d | ||
022 | _a0303-6987 | ||
024 | 7 |
_a10.1111/j.1600-0560.2006.00647.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPerfetto, Brunella | |
245 | 0 | 0 |
_aAnalysis of the signal transduction pathway of nickel-induced matrix metalloproteinase-2 expression in the human keratinocytes in vitro: preliminary findings. _h[electronic resource] |
260 |
_bJournal of cutaneous pathology _cJun 2007 |
||
300 |
_a441-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCell Line, Transformed |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 |
_aDermatitis, Contact _xetiology |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGenistein _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIrritants _xtoxicity |
650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xbiosynthesis |
650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
650 | 0 | 4 |
_aNickel _xtoxicity |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xbiosynthesis |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-2 _xbiosynthesis |
650 | 0 | 4 |
_aTranscription Factor AP-1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aLamberti, Monica | |
700 | 1 | _aGiuliano, Maria Teresa | |
700 | 1 | _aCanozo, Nunzia | |
700 | 1 | _aCammarota, Marcella | |
700 | 1 | _aBaroni, Adone | |
773 | 0 |
_tJournal of cutaneous pathology _gvol. 34 _gno. 6 _gp. 441-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0560.2006.00647.x _zAvailable from publisher's website |
999 |
_c17062525 _d17062525 |